Involvement of oxidative stress in the regulation of NPY/CART-mediated appetite control in amphetamine-treated rats

NeuroToxicology

Volumn 48, Issue , 2015, Pages 131-141

  Hsieh, Yih Shou ^a   Chen, Pei Ni ^a   Yu, Ching Han ^a   Chen, Chia Hui ^a   Tsai, Tsung Ta ^a   Kuo, Dong Yih ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Amphetamine; Appetite; CART; NPY; Oxidative stress

Indexed keywords

AMPHETAMINE; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; NEUROPEPTIDE Y; REACTIVE OXYGEN METABOLITE; ANOREXIGENIC AGENT; ANTISENSE OLIGONUCLEOTIDE; GLUTATHIONE S-TRANSFERASE ALPHA; ISOENZYME; NERVE PROTEIN; SCAVENGER;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DECREASED APPETITE; ENZYME ACTIVITY; FEEDING BEHAVIOR; FOOD INTAKE; HYPOTHALAMUS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; ANIMAL; BRAIN; DRUG EFFECTS; EATING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; TIME; WISTAR RAT;

RATTUS;

AMPHETAMINE; ANIMALS; APPETITE DEPRESSANTS; APPETITE REGULATION; BODY WEIGHT; BRAIN; EATING; FEEDING BEHAVIOR; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; ISOENZYMES; MALE; NERVE TISSUE PROTEINS; NEUROPEPTIDE Y; OLIGONUCLEOTIDES, ANTISENSE; OXIDATIVE STRESS; RATS, WISTAR; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84926295474     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2015.03.011     Document Type: Article

References (65)

1. Andrews Z.B., Liu Z.W., Walllingford N., Erion D.M., Borok E., Friedman J.M., et al. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 2008, 454:846-851.
2. Aronne L.J., Thornton-Jones Z.D. New targets for obesity pharmacotherapy. Clin Pharmacol Ther 2007, 81:748-752.
3. Balkan B., Keser A., Gozen O., Koylu E.O., Dagci T., Kuhar M.J., et al. Forced swim stress elicits region-specific changes in CART expression in the stress axis and stress regulatory brain areas. Brain Res 2012, 1432:56-65.
4. Baez S., Segura-Aguilar J., Widersten M., Johansson A.S., Mannervik B. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 1997, 324:25-28.
5. Benani A., Troy S., Carmona M.C., Fioramonti X., Lorsignol A., Leloup C., et al. Role of mitochondria reactive oxygen species in brain lipid sensing. Diabetes 2007, 56:152-160.
6. Butler A.A., Kesterson R.A., Khong K., Cullen M.J., Pelleymounter M.A., Dekoning J., et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000, 141:3518-3521.
7. Butler A.A. The melanocortin system and energy balance. Peptides 2006, 27:281-290.
8. Chee M.J., Myers M.G., Price C.J., Colmers W.F. Neuropeptide Y suppresses anorexigenic output from the ventromedial nucleus of the hypothalamus. J Neurosci 2010, 30:3380-3390.
9. Chen T.Y., Duh S.L., Huang C.C., Lin T.B., Kuo D.Y. Evidence for the involvement of dopamine D1 and D2 receptors in mediating the decrease of food intake during repeated treatment with amphetamine. J Biomed Sci 2001, 8:462-466.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
11. Chu S.C., Chen P.N., Hsieh Y.S., Yu C.H., Meng-Hsuan L., Yan-Han L., et al. Involvement of hypothalamic PI3K-STAT3 signalling in regulating amphetamine-mediated appetite suppression. Br J Pharmacol 2014, 71:3223-3233.
12. Chu S.C., Chen P.N., Ho Y.J., Yu C.H., Hsieh Y.S., Kuo D.Y. Both neuropeptide Y knockdown and Y1 receptor inhibition modulate CART-mediated appetite control. Horm Behav 2015, 67:38-47.
13. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005, 8:571-578.
14. Cowley M.A., Smart J.L., Rubinstein M., Cerdán M.G., Diano S., Horvath T.L., et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001, 411:480-484.
15. Diano S., Liu Z.W., Jeong J.K., Dietrich M.O., Ruan H.B., Kim E., et al. Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nat Med 2011, 17:1121-1127.
16. dos Santos V.V., Santos D.B., Lach G., Rodrigues A.L., Farina M., De Lima T.C., et al. Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice. Behav Brain Res 2013, 244:107-115.
17. Ehrenbrink G., Hakenhaar F.S., Salomon T.B., Petrucci A.P., Sandri M.R., Benfato M.S. Antioxidant enzymes activities and protein damage in rat brain of both sexes. Exp Gerontol 2006, 41:368-371.
18. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., Hanson G.R. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 2007, 47:681-698.
19. Gillard E.R., Dang D.Q., Stanley B.G. Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake. Brain Res 1993, 628:128-136.
20. Gong L., Yao F., Hockman K., Heng H.H., Morton G.J., Takeda K., et al. Signal transducer and activator of transcription-3 is required in hypothalamic agouti-related protein/neuropeptide Y neurons for normal energy homeostasis. Endocrinology 2008, 149:3346-3354.
21. Hsieh Y.S., Yang S.F., Kuo D.Y. Amphetamine, an appetite suppressant, decreases neuropeptide Y immunoreactivity in rat hypothalamic paraventriculum. Regul Pept 2005, 127:169-176.
22. Hsieh Y.S., Yang S.F., Chen P.N., Chu S.C., Chen C.H., Kuo D.Y. Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats. J Psychopharmacol 2011, 25:982-994.
23. Hsieh Y.H., Chen P.N., Yu C.H., Liao J.M., Kuo D.Y. Inhibiting neuropeptide Y Y1 receptor modulates melanocortin receptor- and NFkB-mediated feeding behavior in phenylpropanolamine-treated rats. Horm Behav 2013, 64:95-102.
24. Hsieh Y.S., Chen P.N., Yu C.H., Kuo D.Y. Central dopamine action modulates neuropeptide-controlled appetite via the hypothalamic PI3K/NFκB-dependent mechanism. Genes Brain Behav 2014, 13:784-793.
25. Hubert G.W., Jones D.C., Moffett M.C., Rogge G., Kuhar M.J. CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system. Biochem Pharmacol 2008, 75:57-62.
26. Hunter R.G., Philpot K., Vicentic A., Dominguez G., Hubert G.W., Kuhar M.J. CART in feeding and obesity. Trends Endocrinol Metab 2004, 15:454-459.
27. Ibrahim N., Bosch M.A., Smart J.L., Qiu J., Rubinstein M., Rønnekleiv O.K., et al. Hypothalamic proopiomelanocortin neurons are glucose responsive and express KATP channels. Endocrinology 2003, 144:1331-1340.
28. Johnson J.A., el Barbary A., Kornguth S.E., Brugge J.F., Siegel F.L. Glutathione S-transferase isoenzymes in rat brain neurons and glia. J Neurosci 1993, 13:2013-2023.
29. Kimmel H.L., Thim L., Kuhar M.J. Activity of various CART peptides in changing locomotor activity in the rat. Neuropeptides 2002, 36:9-12.
30. Kita T1, Miyazaki I., Asanuma M., Takeshima M., Wagner G.C. Opamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. Int Rev Neurobiol 2009, 88:43-64.
31. Koylu E.O., Couceyro P.R., Lambert P.D., Kuhar M.J. Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J Comp Neurol 1998, 391:115-132.
32. Kristensen P., Judge M.E., Thim L., Ribel U., Christjansen K.N., Wulff B.S., et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998, 393:72-76.
33. Kuhar M.J., Dall Vechia S.E. CART peptides: novel addiction- and feeding-related neuropeptides. Trends Neurosci 1999, 22(316):e320.
34. Kuo D.Y., Chen P.N., Yang S.F., Chu S.C., Yu C.H., Hsieh Y.S. Role of reactive oxygen species-related enzymes in neuropeptide Y and proopiomelanocortin-mediated appetite control: a study using atypical protein kinase C knockdown. Antioxid Redox Signal 2011, 2011(15):2147-2159.
35. Kuo D.Y., Chen P.N., Yu C.H., Kuo M.H., Hsieh Y.S., Chu S.C. Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression. Neuropharmacology 2012, 63:842-850.
36. Kuo D.Y., Chen P.N., Chu S.C., Hsieh Y.S. Knocking down the transcript of NF-kappaB modulates the reciprocal regulation of endogenous antioxidants and feeding behavior in phenylpropanolamine-treated rats. Arch Toxicol 2012, 86:453-463.
37. Kuo D.Y., Chen P.N., Hsieh Y.S. Targeting oxidative stress in the hypothalamus: the effect of transcription factor STAT3 knockdown on endogenous antioxidants-mediated appetite control. Arch Toxicol 2015, 89:87-100.
38. Lambert P.D., Couceyro P.R., McGirr K.M., Vechia S.E.D., Smith Y., Kuhar M.J. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 1998, 29:293-298.
39. Magni P., Barnea A. Forskolin and phorbol ester stimulation of neuropeptide Y (NPY) production and secretion by aggregating fetal brain cells in culture: evidence for regulation of NPY biosynthesis at transcriptional and posttranscriptional levels. Endocrinology 1992, 130:976-984.
40. Marcolin Mde L1, Benitz Ade N., Arcego D.M., Noschang C., Krolow R., Dalmaz C. Effects of early life interventions and palatable diet on anxiety and on oxidative stress in young rats. Physiol Behav 2012, 106:491-498.
41. Mercer R.E., Chee M.J., Colmers W.F. The role of NPY in hypothalamic mediated food intake. Front Neuroendocrinol 2011, 32:398-415.
42. Ogawa S., Pfaff D.W. Current status of antisense DNA methods in behavioral studies. Chem Senses 1998, 23:249-255.
43. Pang X., Panee J., Liu X., Berry M.J., Chang S.L., Chang L. Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration. J Neuroimmune Pharmacol 2013, 8:691-704.
44. Parker J.A., Bloom S.R. Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology 2012, 63:18-30.
45. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, Sydney, Australia. 2nd ed.
46. Ritter R.C., Slusser P.G., Stone S. Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 1981, 213:451-452.
47. Rocha M.L., Fernandes P.P., Lotufo B.M., Manhães A.C., Barradas P.C., Tenorio F. Undernutrition during early life alters neuropeptide Y distribution along the arcuate/paraventricular pathway. Neuroscience 2014, 256:379-391.
48. Rogge G., Jones D., Hubert G.W., Lin Y., Kuhar M.J. CART peptides: regulators of body weight, reward and other functions. Nat Rev Neurosci 2008, 9:747-758.
49. Rohner-Jeanrenaud F., Craft L.S., Bridwell J., Suter T.M., Tinsley F.C., Smiley D.L., et al. Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): effects on body weight homeostasis in lean and high-fat-fed obese rats. Int J Obes Relat Metab Disord 2002, 26:143-149.
50. Sahu A., Sninsky C.A., Kalra S.P. Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes. Brain Res 1997, 755:339-342.
51. Sha D., Wang L., Zhang J., Qian L., Li Q., Li J., et al. Cocaine- and amphetamine-regulated transcript peptide increases mitochondrial respiratory chain complex II activity and protects against oxygen-glucose deprivation in neurons. Brain Res 2014, 1582:107-113.
52. Shao L., Cui J., Young L.T., Wang J.F. The effect of mood stabilizer lithium on expression and activity of glutathione S-transferase isoenzymes. Neuroscience 2008, 151:518-524.
53. Sharma R., Yang Y., Sharma A., Awasthi S., Awasthi Y.C. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal 2004, 6:289-300.
54. Shin E.J., Duong C.X., Nguyen X.K., Li Z., Bing G., Bach J.H., et al. Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase C. Behav Brain Res 2012, 232:98-113.
55. Stadlbauer U., Langhans W., Meyer U. Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia. Neuropsychopharmacology 2013, 38:2446-2455.
56. Thrash-Williams B1, Ahuja M., Karuppagounder S.S., Uthayathas S., Suppiramaniam V., Dhanasekaran M. Assessment of therapeutic potential of amantadine in methamphetamine induced neurotoxicity. Neurochem Res 2013, 38:2084-2094.
57. Uchoa E.T1, Silva L.E., de Castro M., Antunes-Rodrigues J., Elias L.L. Glucocorticoids are required for meal-induced changes in the expression of hypothalamic neuropeptides. Neuropeptides 2012, 46:119-124.
58. Vicentic A., Jones D.C. The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction. J Pharmacol Exp Ther 2007, 320:499-506.
59. Vicentic A., Lakatos A., Jones D. The CART receptors: background and recent advances. Peptides 2006, 27:1934-1937.
60. Vrang N., Larsen P.J., Clausen J.T., Kristensen P. Neurochemical characterization of hypothalamic cocaine- amphetamine-regulated transcript neurons. J Neurosci 1999, 19:RC5.
61. Wiehager S., Beiderbeck D.I., Gruber S.H., El-Khoury A., Wamsteeker J., Neumann I.D., et al. Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety. Neurobiol Dis 2009, 34:375-380.
62. Wolden-Hanson T1, Marck B.T., Matsumoto A.M. Blunted hypothalamic neuropeptide gene expression in response to fasting, but preservation of feeding responses to AgRP in aging male Brown Norway rats. Am J Physiol Regul Integr Comp Physiol 2004, 287:R138-R146.
63. Yamamoto B.K1, Moszczynska A., Gudelsky G.A. Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci 2010, 1187:101-121.
64. Younes-Rapozo V., de Moura E.G., da Silva Lima N., Barradas P.C., Manhães A.C., de Oliveira E., et al. Early weaning is associated with higher neuropeptide Y (NPY) and lower cocaine- and amphetamine-regulated transcript (CART) expressions in the paraventricular nucleus (PVN) in adulthood. Br J Nutr 2012, 108:2286-2295.
65. Zhang M., Creese I. Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates. Neurosci Lett 1993, 161:223-226.